Boris Ya. Syropyatov
Boris Ya. Syropyatov publishes mostly in Organic Chemistry, Cancer Research and Polymers and Plastics, on topics such as Chemical synthesis and pharmacological studies, Synthesis and Reactions of Organic Compounds and Synthesis and Characterization of Heterocyclic Compounds.
- World rank
- #7,663,550 of 7,710,434 ranked researchers
- Rank in Russia
- #174,479 of 179,717
- Works
- 100
- Citations
- 332
- Citations per work
- 3.3
What does Boris Ya. Syropyatov research?
Boris Ya. Syropyatov's work is mostly in Chemistry (77%), Biochemistry, Genetics and Molecular Biology (7%), Materials Science (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences8080.5%
- Chemistry7777.0%
- Materials Science43.5%
- Everything else1110.6%
- Life Sciences98.9%
- 1Organic Chemistry75% of their works
- 2Cancer Research5% of their works
- 3Polymers and Plastics4% of their works
- 4Spectroscopy2% of their works
- 5Molecular Biology2% of their works
- 6Plant Science2% of their works
Research topics
- Chemical synthesis and pharmacological studies
- Synthesis and Reactions of Organic Compounds
- Synthesis and Characterization of Heterocyclic Compounds
- Structural and Chemical Analysis of Organic and Inorganic Compounds
- Synthesis and biological activity
- Synthesis and Biological Activity
- Synthesis and Biological Evaluation
- Synthesis of heterocyclic compounds
Which keywords describe Boris Ya. Syropyatov's research?
The keywords of their largest research topics: Synthesis, Cycloaddition Reactions, Heterocycles, Heterocyclic Chemistry, Properties, Catalyst, Antimicrobial and Biological Evaluation.
- Ketene Dithioacetal
- Quinoxaline
- Tetrahydroisoquinoline
- Vascular Targeting Agents
- Triazines
- Oxadiazoles
- Oxazolones
- Medicinal Chemistry
- Biological Evaluation
- Catalyst
- Heterocyclic Chemistry
- Cycloaddition Reactions
- Synthesis
- Heterocycles
- Properties
- Antimicrobial
- Heterocyclic Compounds
- Imidazoles
- Anticancer
- Thiadiazoles
- Tubulin Inhibitors
- Ecteinascidin
- Antimicrobial Activity
- Annulation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Synthesis1096 topics
- Cycloaddition Reactions673 topics
- Heterocycles584 topics
- Heterocyclic Chemistry411 topic
- Properties411 topic
- Catalyst312 topics
- Antimicrobial282 topics
- Biological Evaluation242 topics
- Heterocyclic Compounds232 topics
- Medicinal Chemistry232 topics
- Imidazoles211 topic
- Oxazolones211 topic
- Anticancer141 topic
- Oxadiazoles141 topic
- Thiadiazoles141 topic
- Triazines141 topic
- Tubulin Inhibitors131 topic
- Vascular Targeting Agents131 topic
- Ecteinascidin121 topic
- Tetrahydroisoquinoline121 topic
- Antimicrobial Activity101 topic
- Quinoxaline101 topic
- Annulation91 topic
- Ketene Dithioacetal91 topic
Where does Boris Ya. Syropyatov work?
Boris Ya. Syropyatov's main affiliation in the publication record is Perm State Pharmaceutical Academy, Russia.
How many publications and citations does Boris Ya. Syropyatov have?
OpenAlex counts 100 works and 332 citations for Boris Ya. Syropyatov, an h-index of 8, ranking #7,663,550 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Boris Ya. Syropyatov. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.